Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
PTC Therapeutics (PTCT)
NASDAQ:PTCT
PTC Therapeutics (PTCT) Ownership - Who Owns PTC Therapeutics?
300 Followers
PTC Therapeutics (PTCT) Ownership Overview
20.76% Insiders
41.20% Mutual Funds
20.56% Other Institutional Investors
17.47% Public Companies and
Individual Investors
The ownership structure of PTC Therapeutics (PTCT) stock is a mix of institutional, retail and individual investors. Approximately 61.77% of the company’s stock is owned by Institutional Investors, 20.76% is owned by Insiders and 17.47% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Apr 04, 2024 | Lee Scott Golden Evp & Chief Medical Officer | Sold | $14923 |
| Feb 01, 2024 | Neil Gregory Almstead Chief Technical Ops Officer | Sold | $17604 |
| Feb 01, 2024 | Christine Marie Utter Svp & Cao | Sold | $8666 |
| Feb 01, 2024 | Eric Pauwels Cbo | Sold | $9974 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $156044 | |
| Dec 31, 2023 | Bought | $358913 | |
| Dec 31, 2023 | Sold | $2639641 | |
| Dec 31, 2023 | Bought | $6254521 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 7,145,554 | Institution | 9.33% | 176,423,728 | |
| 6,479,265 | Institution | 8.46% | 159,973,053 | |
| 3,393,863 | Institution | 4.43% | 83,794,477 | |
| 3,348,691 | Institution | 4.37% | 82,679,181 | |
| 2,401,237 | Institution | 3.13% | 59,286,542 | |
| 2,354,772 | Institution | 3.07% | 58,139,321 | |
| 2,333,333 | Insider | 3.05% | 57,609,992 | |
| 1,618,211 | Institution | 2.11% | 39,953,630 | |
| 1,546,111 | Institution | 2.02% | 38,173,481 | |
| 1,502,103 | Institution | 1.96% | 37,086,923 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,479,265 | Institution | 8.46% | 159,973,053 | |
| 3,393,863 | Institution | 4.43% | 83,794,477 | |
| 2,354,772 | Institution | 3.07% | 58,139,321 | |
| 1,618,211 | Institution | 2.11% | 39,953,630 | |
| 1,546,111 | Institution | 2.02% | 38,173,481 | |
| 1,339,220 | Institution | 1.75% | 33,065,342 | |
| 1,217,893 | Institution | 1.59% | 30,069,778 | |
| 1,080,726 | Institution | 1.41% | 26,683,125 | |
| 818,703 | Institution | 1.07% | 20,213,777 | |
| 772,855 | Institution | 1.01% | 19,081,790 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,379,484 | Institution | 3.11% | 69,219,190 | |
| 2,311,323 | Institution | 3.02% | 58,152,887 | |
| 1,925,586 | Institution | 2.51% | 56,015,297 | |
| 1,705,206 | Institution | 2.23% | 42,101,536 | |
| 1,414,183 | Institution | 1.85% | 34,916,178 | |
| 1,128,575 | Institution | 1.47% | 32,830,247 | |
| 1,089,755 | Institution | 1.42% | 31,700,973 | |
| 543,344 | Institution | 0.71% | 13,415,163 | |
| 500,136 | Institution | 0.65% | 12,348,358 | |
| 354,366 | Institution | 0.46% | 8,915,849 |
FAQ
Who Owns PTC Therapeutics (PTCT)?
According to the latest TipRanks data, approximately 20.56% of the company's stock is held by institutional investors, 20.76% is held by insiders, and 17.47% is held by retail investors.
What percentage of PTC Therapeutics (PTCT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 20.56% of PTC Therapeutics (PTCT) stock is held by institutional investors.
What percentage of PTC Therapeutics (PTCT) stock is held by retail investors?
According to the latest TipRanks data, approximately 17.47% of PTC Therapeutics (PTCT) stock is held by retail investors.
Who owns the most shares of PTC Therapeutics (PTCT)?
Vanguard owns the most shares of PTC Therapeutics (PTCT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.